tirzepatide risk of cancer Popular obesity medications significantly lower overall risk, study finds. The breakthrough class obesity medications, including GLP-1 receptor agonists like semaglutide and dual GLP-1/GIP receptor agonists like tirzepatide, continue to make Key Takeaways Patients taking GLP-1

The clinical evidence base for these agents, both individually and in combination, is still emerging

Both drugs are administered once a week and may cause unpleasant gastrointestinal symptoms

Yes, tirzepatide is safe for patients with hypertension on medication, but blood pressure must be monitored closely because tirzepatide typically lowers it further as weight decreases

They can advise based on your specific circumstances (existing diabetes, dose history, other medications)

MNT had the opportunity to speak with Anton Bilchik, MD, PhD, a surgical oncologist, chief of medicine and director of the Gastrointestinal and Hepatobiliary Program at Providence Saint Johns Cancer Institute in Santa Monica, CA, about this study

Whether you take GLP-1 medications or focus on lifestyle changes, our team supports you with expertise and encouragement